Related Experiment Video
Updated: Jun 3, 2026

Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
Sympathetic mechanisms, organ damage, and antihypertensive treatment
Guido Grassi1, Gino Seravalle, Raffaella Dell'Oro
1Clinica Medica, Ospedale S. Gerardo dei Tintori, Via Pergolesi 33, 20052 Monza, Milan, Italy. guido.grassi@unimib.it
Insights
Sympathetic activation, or adrenergic overdrive, drives essential hypertension and its associated end-organ damage. Targeting these neurogenic factors offers potential therapeutic strategies for hypertension complications.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Hypertension Research
Background:
- Essential hypertension is characterized by sympathetic nervous system activation.
- Adrenergic overdrive contributes to the pathogenesis of hypertension and its complications.
Purpose of the Study:
- To review recent evidence on the role of neurogenic factors in hypertension-related end-organ damage.
- To highlight therapeutic implications of targeting adrenergic overdrive.
Main Methods:
- Review of accumulated evidence from the past few years.
- Analysis of studies documenting neurogenic factors in end-organ damage.
Main Results:
- Sympathetic activation is crucial in hypertension development and progression.
- Adrenergic overdrive contributes to cardiac hypertrophy, diastolic dysfunction, heart failure, and vascular alterations.
- Neurogenic factors play a role in renal insufficiency and failure associated with hypertension.
Conclusions:
- Neurogenic factors are integral to the development and progression of end-organ damage in hypertension.
- Therapeutic strategies targeting adrenergic overdrive show promise for managing hypertension complications.
Abstract:
Sympathetic activation characterizes essential hypertension, contributing to the development and progression of the high blood pressure state. Throughout the years, evidence has been accumulated to show that adrenergic overdrive also participates in the pathogenesis of the end-organ damage associated with hypertension, including cardiac hypertrophy, left ventricular diastolic dysfunction, and heart failure, as well as the vascular structural and functional alterations that frequently can be detected in large, medium-size, and small arteries. Adrenergic overdrive also participates in the renal insufficiency and failure that may accompany the clinical course of the hypertensive state. This paper reviews evidence collected over the past few years documenting the importance of neurogenic factors in the development and progression of end-organ damage. The therapeutic implications of this evidence are also highlighted.
Related Concept Videos
Hypertension II: Pathophysiology
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hypertension III: Clinical Manifestations and Diagnostic Studies
